The company says it’s “working to return to full capacity as soon as local authorities allow” and the plant is now back at 50 percent capacity, according to Bloomberg.
Elliott Haut, MD, PhD, a trauma surgeon who oversees quality and safety at the Department of Surgery at the Johns Hopkins School of Medicine in Baltimore, told the publication the shortage “is probably one of the biggest risks for patient safety since COVID hit,” as it could complicate efforts to diagnose and treat serious conditions, such as strokes, heart attacks and lung clots.
The American Hospital Association urged GE Healthcare in a May 16 letter to distribute supplies based on need while the shortage persists.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
